Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

Share Price is delayed by 15 minutes
Get Live Data
317.50    0.50 (0.16%)
Bid:
315.50
Ask:
317.00
Spread: 1.50 (0.475%)
Market Cap: £732.37m
CSN Live PriceLast checked at - London Stock Exchange

Intraday Chesnara Share Chart

Proposed Acquisition

13 Sep 2021 07:00

RNS Number : 4855L
Chesnara PLC
13 September 2021
 

 

 

 

Chesnara PLC

("Chesnara" or the "Company")

 

 

13 September 2021

 

 

ACQUISITION

 

CHESNARA ENHANCES SCALE IN THE UK WITH THE ACQUISITION OF SANLAM LIFE & PENSIONS UK LIMITED

 

 

TRANSACTION HIGHLIGHTS:

 

§ Chesnara has entered into an agreement with Sanlam UK Limited to acquire Sanlam Life & Pensions UK Limited (SLP), a specialist provider of insurance and long-term savings products in the UK.

§ Enhances the scale of its operations in the UK by adding £2.9bn of assets under administration and c.80,000 policies.

§ Cash consideration of £39.0m funded from Chesnara's existing debt facility.

§ £48.1m estimated SLP Economic Value ("EcV")[1] on a Chesnara defined basis.

§ Material further commercial value upside potential supporting Chesnara's progressive dividend strategy.

§ Completion is expected to occur in early 2022, conditional upon customary regulatory approvals.

 

 

STRATEGIC RATIONALE AND BENEFITS OF THE TRANSACTION:

 

§ Scale enhancement: SLP's specialist pension and long-term savings propositions and risk profile are well aligned with Chesnara's existing life and pension liability mix in the UK. Adds c80,000 additional policies and increases Chesnara group AuA by 34% to £11.4bn at the end of 2020 and UK AuA by 126% to £5.2bn.

§ Attractive financial terms: Cash consideration of £39.0m represents an attractive discount to estimated EcV of £48.1m, providing an incremental EcV per share of 4p after deal costs. Provides future material value creation potential from expense and capital synergies, real world returns above risk free and risk margin run-off which will add further EcV accretion over time.

§ Enhanced dividend support: Incremental cash generation of c£5m per annum under steady state conditions, supporting Chesnara's progressive dividend strategy.

§ Preserved financial flexibility: Including the impact of the acquisition, Chesnara's pro forma estimated year-end 2020 Solvency II ratio would remain strong and within our target operating range at 142%. Chesnara's debt leverage ratio will remain low at 15%, leaving the Company with further financing capacity for additional transactions.

§ Integration into our UK platform: the SLP business will be integrated into Countrywide Assured plc, Chesnara's UK platform, and will follow its tried and tested business model as a focused, closed-book consolidator. SLP will retain a commercial relationship with Sanlam Investments UK Limited for investment management.

 

 

COMMENTS ON THE TRANSACTION:

 

John Deane, Chief Executive Officer, Chesnara stated: 

 

"We are delighted to announce this transaction which will expand the scale of our UK operations and deliver potential for material value creation for Chesnara. The expected incremental cash generation from SLP will enhance the sustainability of our progressive dividend strategy.

 

SLP's business is well aligned to Chesnara's acquisition strategy and will be integrated with our existing UK operations. We look forward to welcoming SLP's customers and staff to the Chesnara group and continuing to work with Sanlam on the management of SLP assets.

 

We believe that the market prospects for further acquisitions across our target markets remain positive and we continue to be confident in our ability to finance and execute such transactions on attractive terms for both vendors and our shareholders."

 

Jonathan Polin, Chief Executive Officer, Sanlam UK Limited stated:

 

"This deal is a testament to the strength and quality of SLP and its long-standing track record of excellent client service. I would like to thank all my colleagues there for their unstinting efforts. Chesnara is a highly respected and established life insurance and pensions consolidator and I am confident that the business will flourish under its new ownership for the benefit of all its key stakeholders, including policyholders."

 

 

 

 

Enquiries

 

Chesnara

John Deane, Chief Executive Officer - 01772 972079

Steve Murray, Chief Executive Officer (Designate) - 01772 972079

David Rimmington, Chief Financial Officer - 01772 972079

 

FWD Consulting

Roddy Watt - 0207 280 0651 / 07714 770493 

 

 

Notes to Editors

 

LEI Number: 213800VFRMBRTSZ3SJ06

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 (as it forms part of retained EU law as defined in the European Union (Withdrawal) Act 2018).

 

About Chesnara plc

 

Chesnara is a life and pensions consolidator listed on the London Stock Exchange. It administers approximately 900,000 policies with approximately £8.7 billion of assets under management as at 30 June 2021, with those assets spread broadly equally across businesses in the UK, the Netherlands and Sweden. Chesnara operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands, and as Movestic in Sweden.

 

Following a three pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing profitable new business in Sweden and the Netherlands and by undertaking value-adding acquisitions of either companies or portfolios.

 

Chesnara has a proven track record of acquiring and consolidating life and pension portfolios and businesses. The acquisition that is the subject of this press release is evidence of the continuation of this capability. The acquisition process adds value for our shareholders whilst also providing a solution for vendors to realise value and release capital. This is achieved by vendors divesting life and pensions businesses or portfolios which are not core to their wider strategic focus, or where diminishing scale creates operational and hence financial viability pressure. Chesnara's robust regulatory framework and strong solvency ensures policyholder interests are well protected and remain at the heart of any divestment decision.

 

Consistent delivery of the company strategy has enabled Chesnara to increase its dividend for 17 years in succession.

 

Further details are available on the Company's website (www.chesnara.co.uk).

 

About Sanlam Life & Pensions UK Limited (SLP)

 

SLP is specialist provider of insurance and long-term savings, with key products of unit-linked pensions and SIPPs, aimed primarily at affluent and high net worth private clients in the UK.

 

SLP is part of Sanlam UK Limited, a financial services group offering wealth management, life and pension insurance products and asset management services. Sanlam UK Limited is a wholly-owned subsidiary of Sanlam Limited, an international financial services group headquartered in South Africa and listed on the Johannesburg, A2X and Namibia stock exchanges.

 

Key financial data for SLP:

 

£m, unless stated

31 December 2020

Alternative performance measures

AuA (£bn)

2.9

Policies (thousands)

80

IFRS

Result after tax

(2.4)

Total assets

2,976.3

Shareholders' equity

32.1

Solvency II

Own Funds (1)

58.5

Unrestricted Tier 1 / Own Funds (%)

100

Solvency ratio (%) (1)

133

 

(1) As reported under the SLP basis of preparation

 

Important Notice

 

This announcement contains forward-looking statements with respect to the operations, performance and financial condition of Chesnara. By their nature, these statements are subject to risks, assumptions and uncertainties that could cause actual results to differ materially from those expressed or implied because they relate to future events. Unless otherwise required by applicable law, regulation or accounting standard, the Company does not undertake to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise. Nothing in this document should be construed as a profit forecast.

 

Nothing contained in this announcement constitutes or shall be deemed to constitute an offer or invitation to invest in otherwise deal in any shares or other securities of Chesnara.


[1] Chesnara estimate, as of 31 December 2020

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQDKBBKKBKBBCD
Date   Source Headline
10th Aug 201511:22 amRNSNotice of Results
20th May 20157:00 amRNSAcquisition
15th May 201511:56 amRNSResult of AGM
11th May 20154:17 pmRNSRegulatory Approval
28th Apr 20153:40 pmRNSDirector/PDMR Shareholding
27th Apr 20159:51 amRNSAnnual Financial Report
15th Apr 20157:00 amRNSAnnual Report and Accounts and Notice of AGM
31st Mar 20157:00 amRNSFinal Results
9th Mar 20158:48 amRNSNotice of Results
25th Feb 20159:29 amRNSHolding(s) in Company
21st Jan 20154:01 pmRNSDirector/PDMR Shareholding
5th Dec 20147:00 amRNSRegulatory Approval
4th Dec 201412:30 pmRNSPart VII Transfer Approval
3rd Dec 201412:58 pmRNSResults of Placing
3rd Dec 20147:01 amRNSProposed Acquisition and Placing
3rd Dec 20147:00 amRNSDirectorate Change
19th Nov 20147:00 amRNSInterim Management Statement
7th Nov 201412:54 pmRNSTotal Voting Rights
4th Nov 201410:18 amRNSDirector/PDMR Shareholdings / Total Voting Rights
9th Sep 20142:39 pmRNSHolding(s) in Company
29th Aug 20147:00 amRNSHalf Yearly Report
11th Aug 20144:01 pmRNSNotice of Results
21st Jul 201411:42 amRNSTotal Voting Rights
7th Jul 20141:41 pmRNSContract with HCL
19th Jun 20142:06 pmRNSDirectorate Change
20th May 20142:43 pmRNSDirector/PDMR Shareholding
19th May 20147:00 amRNS1st Quarter Results
16th May 201411:40 amRNSResult of AGM
28th Apr 201411:42 amRNSAnnual Financial Report
14th Apr 201412:26 pmRNSAnnual Report and Accounts and Notice of AGM
28th Mar 20141:28 pmRNSDirector/PDMR Shareholding
28th Mar 20147:01 amRNSFinal Results
10th Mar 201412:00 pmRNSNotice of Results
3rd Feb 201411:41 amRNSHolding(s) in Company
21st Jan 20141:56 pmRNSHolding(s) in Company
16th Jan 201410:27 amRNSHolding(s) in Company
28th Nov 20132:00 pmRNSAcquisition
19th Nov 20137:00 amRNS3rd Quarter Interim Management Statement
7th Nov 201311:55 amRNSResult of Meeting
22nd Oct 20135:30 pmRNSStatement re: Posting Circular to Shareholders
8th Oct 20137:00 amRNSSale of Direct Line Life & proposed capital return
8th Oct 20137:00 amRNSAcquisition
30th Aug 20137:00 amRNSHalf Yearly Report
12th Aug 20139:42 amRNSNotice of Results
31st Jul 20139:15 amRNSTotal Voting Rights
4th Jul 201310:10 amRNSListing Rule 9.6.14
28th Jun 20139:01 amRNSTotal Voting Rights
11th Jun 20138:30 amRNSDirectorate Change
22nd May 20133:59 pmRNSHolding(s) in Company
17th May 201311:37 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.